Dr Martens Plc Stock Market Capitalization
| DOCMF Stock | USD 0.72 0.02 2.86% |
Dr Martens plc fundamentals help investors to digest information that contributes to Dr Martens' financial success or failures. It also enables traders to predict the movement of DOCMF Pink Sheet. The fundamental analysis module provides a way to measure Dr Martens' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Dr Martens pink sheet.
DOCMF |
Dr Martens plc Company Market Capitalization Analysis
Dr Martens' Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Current Dr Martens Market Capitalization | 1.93 B |
Most of Dr Martens' fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Dr Martens plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
| Competition |
Based on the recorded statements, the market capitalization of Dr Martens plc is about 1.93 B. This is 87.5% lower than that of the Consumer Cyclical sector and 99.15% lower than that of the Footwear & Accessories industry. The market capitalization for all United States stocks is 89.83% higher than that of the company.
DOCMF Market Capitalization Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Dr Martens' direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Dr Martens could also be used in its relative valuation, which is a method of valuing Dr Martens by comparing valuation metrics of similar companies.Dr Martens is currently under evaluation in market capitalization category among its peers.
DOCMF Fundamentals
| Return On Equity | 0.64 | |||
| Return On Asset | 0.16 | |||
| Profit Margin | 0.19 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 2.75 B | |||
| Shares Outstanding | 1 B | |||
| Shares Owned By Insiders | 3.85 % | |||
| Shares Owned By Institutions | 69.40 % | |||
| Price To Earning | 33.56 X | |||
| Price To Book | 5.71 X | |||
| Price To Sales | 2.43 X | |||
| Revenue | 908.3 M | |||
| Gross Profit | 578.8 M | |||
| EBITDA | 265 M | |||
| Net Income | 181.2 M | |||
| Cash And Equivalents | 228 M | |||
| Cash Per Share | 0.23 X | |||
| Total Debt | 280.9 M | |||
| Debt To Equity | 1.20 % | |||
| Current Ratio | 2.86 X | |||
| Book Value Per Share | 0.35 X | |||
| Cash Flow From Operations | 184.4 M | |||
| Earnings Per Share | 0.21 X | |||
| Price To Earnings To Growth | 0.01 X | |||
| Number Of Employees | 2.23 K | |||
| Beta | 0.0551 | |||
| Market Capitalization | 1.93 B | |||
| Total Asset | 859.1 M | |||
| Z Score | 4.6 | |||
| Annual Yield | 0.04 % | |||
| Net Asset | 859.1 M | |||
| Last Dividend Paid | 0.058 |
About Dr Martens Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Dr Martens plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dr Martens using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dr Martens plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in DOCMF Pink Sheet
Dr Martens financial ratios help investors to determine whether DOCMF Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in DOCMF with respect to the benefits of owning Dr Martens security.